Andrew M. Paluch - Concepedia

Author

Andrew M. Paluch

University of Cincinnati Medical Center

Also Known As

A M Paluch, Andrew M Paluch, Andrew M. Paluch, Andrew Paluch

Publications

406

Citations

H-Index

Concepts

All Affiliations

University of Cincinnati Medical Center Veterans Health Administration Cincinnati Children's Hospital Medical Center

About

Andrew M. Paluch is an author at University of Cincinnati Medical Center specializing in medicine, urology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	335
2	Cell Biology	2	2	66
3	Health Sciences	1	1	10
4	Allergy	1	1	246
5	Diabetes	1	1	10

Andrew M. Paluch

Publications

406

Citations

H-Index

Page 1

	Year	Citations
Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor Molly M. McFarland-Mancini, Holly M. Funk, Andrew M. Paluch, The Journal of Immunology InflammationCytokineAllergyImmunologyImmune Regulation	2010	246
Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis Yuqi Cai, David Balli, Vladimir Ustiyan, Journal of Biological Chemistry	2013	58
The Ron receptor promotes prostate tumor growth in the TRAMP mouse model Megan N. Thobe, Jerilyn K. Gray, Devikala Gurusamy, Oncogene UrologyPerineural InvasionHormonal ReceptorTumor GrowthReceptor (Biochemistry)	2011	52
Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation Nicholas E. Brown, Andrew M. Paluch, Madison A. Nashu, Neoplasia Androgen ReceptorAndrogen DeprivationTumor BiologyReceptor Tyrosine KinaseCancer Cell Biology	2018	14
Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia Jerilyn K. Gray, Andrew M. Paluch, William D. Stuart, Cancer Letters UrologyPerineural InvasionIntraepithelial NeoplasiaGenitourinary CancerRon Receptor Overexpression	2011	13
Safety and efficacy of AMG 160, a half-life extended BiTE immune therapy targeting prostate-specific membrane antigen (PSMA), and other therapies for metastatic castration-resistant prostate cancer (mCRPC). Sumit K. Subudhi, Bilal A. Siddiqui, Joseph Maly, Journal of Clinical Oncology ImmunologyImmunoeditingBite Immune TherapyAmg 160Immunotherapeutics	2021	13
Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice William D. Stuart, Nicholas E. Brown, Andrew M. Paluch, American Journal of Physiology-Endocrinology and Metabolism ImmunologyRon Tyrosine KinaseHigh-fat DietFatty Liver DiseaseInsulin Signaling	2015	10

Page 1